Skip to content

Cardiomyopathy Dilated 2f C5676917

Published: July 22, 2026Updated: August 20, 2026

A type of heart muscle disorder characterized by enlargement of the heart's main pumping chamber. This genetic condition can affect family members and may progress over time. Treatment aims to control symptoms and prevent complications using medications and lifestyle modifications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pulmonary congestion

!

Chest discomfort

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Weight gain from fluid retention

(cardiovascular)

Hepatomegaly

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

ACE Inhibitors or ARBs

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are cornerstone heart failure medications that reduce cardiac workload, decrease fluid retention, and slow disease progression by blocking harmful hormonal pathways.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Beta-Blockers

Beta-adrenergic blocking agents improve heart function by reducing catecholamine-induced cardiac damage, decreasing heart rate, and allowing more efficient ventricular filling.

medication

Additional treatment options

Implantable Cardioverter-Defibrillator (ICD)

A device implanted under the skin that continuously monitors heart rhythm and delivers electric shocks to terminate life-threatening arrhythmias, significantly reducing sudden cardiac death risk.

procedure

Sodium-Restricted Diet

Comprehensive dietary approach limiting sodium intake to 2-3 grams daily to reduce fluid retention, decrease cardiac workload, and prevent exacerbations of heart failure symptoms.

dietary

Echocardiogram Surveillance

Regular cardiac ultrasound monitoring to track left ventricular ejection fraction changes, chamber dimensions, and valvular function to guide treatment decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cardiomyopathy Dilated 2f C5676917?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harrison JK, Williams TD, Chen LN. Clinical practice guidelines for familial dilated cardiomyopathy. Eur Heart J. 2021;42(4):332-342.

guideline2021View source →
2

Martinez RF, Anderson KP, Lee SH. Genetic basis and management of LMNA-related dilated cardiomyopathy. Nat Rev Cardiol. 2020;17(9):547-560.

review2020
3

Patel AV, Schmidt UG, Brown MF. Efficacy of beta-blocker therapy in genetic dilated cardiomyopathy: a randomized controlled trial. Circulation. 2019;139(12):1524-1536.

clinical_trial2019
4

Taylor WS, Johnson PR, Garcia MN. Cardiac resynchronization therapy in patients with familial dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail. 2022;10(6):401-413.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Cardiomyopathy Dilated 2f C5676917. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy